FDA REPORT ON DIETARY SUPPLEMENT MANUFACTURING QUALITY
This article was originally published in The Tan Sheet
FDA REPORT ON DIETARY SUPPLEMENT MANUFACTURING QUALITY is requested by the House Appropriations Committee in its report on the fiscal 1995 FDA spending bill. The committee said it "has received testimony regarding inferior quality dietary supplements." According to the committee, "due to the lack of established good manufacturing practice standards, many dietary supplements will dissolve and release differently because of manufacturing differences."
You may also be interested in...
Perrigo promotes in pricing, planning
Combe sells most of its OTC brands
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC